Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin type A plus physical therapy versus physical therapy alone in children with cerebral palsy
RBR-6dctww5Not yet recruiting
- Sponsor
- Hospital Universitário Bettina Ferro de Souza
- Start
- Jan 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised, open-label trial of botulinum toxin type A in cerebral palsy (CP) (4 arms), sponsored by Hospital Universitário Bettina Ferro de Souza. Primary endpoints: Movement outcomes at 180 days, Postural balance at 180 days and 2 more. Planned start Jan 2023; status: not yet recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
cerebral palsy (CP)
Beyond the preview
Go deeper on RBR-6dctww5.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-6dctww5.